• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合蛋白质组学特征揭示三阴性乳腺癌中的亚型特异性分子异常。

Comprehensive Proteomic Characterization Reveals Subclass-Specific Molecular Aberrations within Triple-negative Breast Cancer.

作者信息

Kosok Max, Alli-Shaik Asfa, Bay Boon Huat, Gunaratne Jayantha

机构信息

Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore 138673, Singapore; Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117594, Singapore.

Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore 138673, Singapore.

出版信息

iScience. 2020 Feb 21;23(2):100868. doi: 10.1016/j.isci.2020.100868. Epub 2020 Jan 28.

DOI:10.1016/j.isci.2020.100868
PMID:32058975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7015993/
Abstract

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer lacking targeted therapies. This is attributed to its high heterogeneity that complicates elucidation of its molecular aberrations. Here, we report identification of specific proteome expression profiles pertaining to two TNBC subclasses, basal A and basal B, through in-depth proteomics analysis of breast cancer cells. We observed that kinases and proteases displayed unique expression patterns within the subclasses. Systematic analyses of protein-protein interaction and co-regulation networks of these kinases and proteases unraveled dysregulated pathways and plausible targets for each TNBC subclass. Among these, we identified kinases AXL, PEAK1, and TGFBR2 and proteases FAP, UCHL1, and MMP2/14 as specific targets for basal B subclass, which represents the more aggressive TNBC cell lines. Our study highlights intricate mechanisms and distinct targets within TNBC and emphasizes that these have to be exploited in a subclass-specific manner rather than a one-for-all TNBC therapy.

摘要

三阴性乳腺癌(TNBC)是最具侵袭性的乳腺癌亚型,缺乏靶向治疗方法。这归因于其高度异质性,使得阐明其分子畸变变得复杂。在此,我们报告通过对乳腺癌细胞进行深入的蛋白质组学分析,鉴定出与两种TNBC亚类(基底A和基底B)相关的特定蛋白质组表达谱。我们观察到激酶和蛋白酶在亚类中呈现出独特的表达模式。对这些激酶和蛋白酶的蛋白质-蛋白质相互作用及共调控网络进行系统分析,揭示了每个TNBC亚类失调的途径和可能的靶点。其中,我们鉴定出激酶AXL、PEAK1和TGFBR2以及蛋白酶FAP、UCHL1和MMP2/14是基底B亚类的特定靶点,基底B亚类代表更具侵袭性的TNBC细胞系。我们的研究突出了TNBC内部复杂的机制和不同的靶点,并强调必须以亚类特异性的方式加以利用,而不是采用一种适用于所有TNBC的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/c003a9aeda7d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/179cac665e19/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/604a4ab65757/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/e11c40803d05/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/858e72271c2a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/bf1f00719c62/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/013f560d237c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/c003a9aeda7d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/179cac665e19/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/604a4ab65757/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/e11c40803d05/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/858e72271c2a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/bf1f00719c62/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/013f560d237c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e997/7015993/c003a9aeda7d/gr6.jpg

相似文献

1
Comprehensive Proteomic Characterization Reveals Subclass-Specific Molecular Aberrations within Triple-negative Breast Cancer.综合蛋白质组学特征揭示三阴性乳腺癌中的亚型特异性分子异常。
iScience. 2020 Feb 21;23(2):100868. doi: 10.1016/j.isci.2020.100868. Epub 2020 Jan 28.
2
Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.NOD1 和 NOD2 受体过表达的三阴性乳腺癌细胞的蛋白质组谱分析揭示了恶性细胞增殖的分子特征。
BMC Genomics. 2019 Feb 21;20(1):152. doi: 10.1186/s12864-019-5523-6.
3
Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer.基于蛋白质组学的三阴性乳腺癌的跨组学特征分析及综合网络分析。
Cell Rep. 2022 Mar 1;38(9):110460. doi: 10.1016/j.celrep.2022.110460.
4
Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.长非编码 RNA:在人类非三阴性和三阴性乳腺癌的靶向诊断、预后和改进治疗策略中的意义。
Clin Epigenetics. 2018 Jun 27;10:88. doi: 10.1186/s13148-018-0514-z. eCollection 2018.
5
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities.三阴性乳腺癌细胞的代谢谱揭示了代谢弱点。
Cancer Metab. 2017 Aug 22;5:6. doi: 10.1186/s40170-017-0168-x. eCollection 2017.
6
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).三阴性乳腺癌(TNBC)中对比途径的探索。
BMC Cancer. 2018 Jan 4;18(1):22. doi: 10.1186/s12885-017-3939-4.
7
iTRAQ-Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple-Negative Breast Cancer Tumors.基于 iTRAQ 的定量蛋白质组学分析加强了三阴性乳腺癌肿瘤的转录组亚分型。
Proteomics. 2019 Nov;19(21-22):e1800484. doi: 10.1002/pmic.201800484. Epub 2019 May 7.
8
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.基于组学整合的通路分析揭示 CYP 加单氧酶相关网络作为转移性三阴性乳腺癌的治疗靶点。
J Exp Clin Cancer Res. 2019 May 9;38(1):187. doi: 10.1186/s13046-019-1187-y.
9
Biomarkers in triple negative breast cancer: A review.三阴性乳腺癌中的生物标志物:综述
World J Clin Oncol. 2015 Dec 10;6(6):252-63. doi: 10.5306/wjco.v6.i6.252.
10
Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes.TCGA 中三阴性乳腺癌亚组的乳腺癌特征的综合分析揭示了新的 miRNA 特异性簇,包括 miR-17-92a,可区分基底样 1 和基底样 2 三阴性乳腺癌亚型。
BMC Cancer. 2020 Feb 21;20(1):141. doi: 10.1186/s12885-020-6600-6.

引用本文的文献

1
Profiling triple-negative breast cancer-specific super-enhancers identifies high-risk mesenchymal development subtype and BETi-Targetable vulnerabilities.对三阴性乳腺癌特异性超级增强子进行分析可识别高危间充质发育亚型及溴结构域和末端外结构域抑制剂(BETi)可靶向的脆弱性。
Mol Cancer. 2025 May 13;24(1):141. doi: 10.1186/s12943-025-02342-6.
2
Advancements in Single-Cell Proteomics and Mass Spectrometry-Based Techniques for Unmasking Cellular Diversity in Triple Negative Breast Cancer.单细胞蛋白质组学及基于质谱技术在揭示三阴性乳腺癌细胞多样性方面的进展
Proteomics Clin Appl. 2025 Jan;19(1):e202400101. doi: 10.1002/prca.202400101. Epub 2024 Nov 21.
3

本文引用的文献

1
Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis.去泛素化酶活性分析鉴定 UCHL1 为促进 TGFβ 诱导的乳腺癌转移的候选癌蛋白。
Clin Cancer Res. 2020 Mar 15;26(6):1460-1473. doi: 10.1158/1078-0432.CCR-19-1373. Epub 2019 Dec 19.
2
Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer.三阴性乳腺癌中 CDK12/CDK13 的治疗靶点。
Cancer Cell. 2019 Nov 11;36(5):545-558.e7. doi: 10.1016/j.ccell.2019.09.004. Epub 2019 Oct 24.
3
TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation.
FlexStat: combinatory differentially expressed protein extraction.
FlexStat:组合差异表达蛋白提取法
Bioinform Adv. 2024 Apr 11;4(1):vbae056. doi: 10.1093/bioadv/vbae056. eCollection 2024.
4
Multiomics analyses reveal dynamic bioenergetic pathways and functional remodeling of the heart during intermittent fasting.多组学分析揭示了间歇性禁食期间心脏的动态生物能量途径和功能重塑。
Elife. 2023 Sep 28;12:RP89214. doi: 10.7554/eLife.89214.
5
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells.靶向HER3可增强帕比司他对Claudin低表达三阴性乳腺癌细胞的疗效。
NPJ Precis Oncol. 2023 Aug 3;7(1):72. doi: 10.1038/s41698-023-00422-8.
6
Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping.三阴性乳腺癌亚型分类的可靠性和可重复性的重新评估
Cancers (Basel). 2022 May 24;14(11):2571. doi: 10.3390/cancers14112571.
7
The Role of Extracellular Matrix Proteins in Breast Cancer.细胞外基质蛋白在乳腺癌中的作用
J Clin Med. 2022 Feb 25;11(5):1250. doi: 10.3390/jcm11051250.
8
Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer.当前三阴性乳腺癌亚型:剖析最具侵袭性的乳腺癌形式。
Front Oncol. 2021 Jun 16;11:681476. doi: 10.3389/fonc.2021.681476. eCollection 2021.
9
The Roles of DNA Demethylases in Triple-Negative Breast Cancer.DNA去甲基化酶在三阴性乳腺癌中的作用
Pharmaceuticals (Basel). 2021 Jun 29;14(7):628. doi: 10.3390/ph14070628.
10
AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network.AXL 通过劫持 PEAK1 调节的焦点黏附蛋白网络促进细胞迁移和侵袭。
Nat Commun. 2020 Jul 17;11(1):3586. doi: 10.1038/s41467-020-17415-x.
TGF-β 诱导的转谷氨酰胺酶通过调节上皮-间充质转化和侵袭伪足形成促进膀胱癌转移。
EBioMedicine. 2019 Sep;47:208-220. doi: 10.1016/j.ebiom.2019.08.012. Epub 2019 Aug 13.
4
ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer.ROR1增强基底样乳腺癌中的FGFR信号传导。
Cancers (Basel). 2019 May 24;11(5):718. doi: 10.3390/cancers11050718.
5
CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease.乳腺癌中的CDK4/6抑制剂:超越激素受体阳性、人表皮生长因子受体2阴性疾病
Ther Adv Med Oncol. 2018 Dec 17;10:1758835918818346. doi: 10.1177/1758835918818346. eCollection 2018.
6
Synergistic anti-cancer activity of CDK4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing ER-negative breast cancer.CDK4/6 抑制剂帕博西尼与双重 mTOR 激酶抑制剂 MLN0128 联合应用于表达 pRb 的 ER 阴性乳腺癌的协同抗癌活性。
Breast Cancer Res Treat. 2019 Apr;174(3):615-625. doi: 10.1007/s10549-018-05104-9. Epub 2019 Jan 3.
7
Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells.LYN 激酶失调的双重机制驱动乳腺癌细胞的侵袭行为。
Cell Rep. 2018 Dec 26;25(13):3674-3692.e10. doi: 10.1016/j.celrep.2018.11.103.
8
The PRIDE database and related tools and resources in 2019: improving support for quantification data.PRIDE 数据库及相关工具和资源在 2019 年的进展:提高定量数据支持。
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450. doi: 10.1093/nar/gky1106.
9
N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer.N-钙黏蛋白在癌症转移中的作用、其在血液系统恶性肿瘤中日益凸显的作用以及作为癌症治疗靶点的潜力。
BMC Cancer. 2018 Oct 1;18(1):939. doi: 10.1186/s12885-018-4845-0.
10
RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE.RON 受体酪氨酸激酶作为根除三阴性乳腺癌的治疗靶点:抗 RON ADC Zt/g4-MMAE 的疗效。
Mol Cancer Ther. 2018 Dec;17(12):2654-2664. doi: 10.1158/1535-7163.MCT-18-0252. Epub 2018 Oct 1.